CambridgeD.DaveyM. J.MassinghamR.: The Pharmacology of Antihypertensive Drugs with Special Reference to Vasodilators, Alpha-Adrenergic Blocking Agents and Prazosin, Med. J. Aust.2 (suppl.): 2–6, 1977.
2.
HessH. J.: Biochemistry and Structure — Activity Studies with Prazosin in Prazosin: Evaluation of a New Antihypertensive Agent. Edited by CottonDWK, Excerpta Medica, 1974. pp. 3–15.
3.
WoodA. J.PhelanE. L.SimpsonF. O.: Cardiovascular Effects of Prazosin in Normotensive and Genetically Hypertensive Rats, Clin. Pharmacol. Phys.2: 297, 1975.
4.
CollinsI. S.PekP.: Pharmacokinetics of Prazosin, A New Antihypertensive Compound, Clin. Exp. Pharmacol. Physiol.2: 445, 1975.
5.
GrahamR. M.ThornellI. R.GainJ. M.: Prazosin: The First Dose Phenomenon, Br. Med. J.4: 1293–1294, 1976.
6.
RosendorffC.: Prazosin: Severe Side Effects are Dose Dependent, Br. Med. J.3: 508, 1976.
7.
StokesG. S.GrahamR. M.GainJ. M.: Influence of Dosage and Dietary Sodium on the First Dose Effects of Prazosin, Br. Med. J.1: 1507–1508, 1977.
8.
MillerR. R.AwanN. A.MaxwellK. S.: Sustained Reduction of Cardiac Impedence and Preload in Congestive Heart Failure with the Antihypertensive Vasodilator Prazosin, N. Engl. J. Med.297: 303–307, 1977.
